Hexane

Hexane

SCHEMBL6284358

CC(C)(C)N.CCCCCC

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Hexane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.54
THRB P10828 1/20 0.54
DNM1 Q05193 8/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 1/20 0.47
EPHX1 P07099 1/20 0.47
LMNA P02545 1/20 0.46
FDPS P14324 2/20 0.42
SLC22A1 O15245 2/20 0.41
SLC22A2 O15244 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
OPRM1 P35372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptane SCHEMBL29184837 0.96 TSHR (0.61) TSHRTHRBDNM1MEN1KMT2A
Hexane SCHEMBL10873258 0.88 TSHR (0.50) TSHRTHRBDNM1MEN1KMT2A
Hexane SCHEMBL10976180 0.87 TSHR (0.58) TSHRTHRBDNM1MEN1KMT2A
Tert-Butylamine SCHEMBL1570191 0.87 DNM1 (0.71) TSHRTHRBDNM1MEN1KMT2A
Decylamine SCHEMBL28061292 0.84 DNM1 (0.77) TSHRTHRBDNM1MEN1KMT2A
Tert-Butylamine SCHEMBL5515778 0.84 DNM1 (0.77) TSHRTHRBDNM1MEN1KMT2A
Tert-Butylamine SCHEMBL29180642 0.84 DNM1 (0.77) TSHRTHRBDNM1MEN1KMT2A
Tert-Butylamine SCHEMBL3416795 0.82
Hexane SCHEMBL28709670 0.82 TSHR (0.64) TSHRTHRBDNM1MEN1KMT2A
Tert-Butylamine SCHEMBL7902820 0.82 DNM1 (0.56) TSHRDNM1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919291-B2 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-07-19 US disclosed
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2004-06-10 US disclosed
EP-1349653-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2003-10-08 EP disclosed
WO-2002036639-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization FZD7, FOS, COG4 TSHR 4247/4885THRB 4357/4885DNM1 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.